Siga Technologies INC Increase (Decrease) in Accrued Interest Receivable, Net
Siga Technologies INC (SIGA) reported Increase (Decrease) in Accrued Interest Receivable, Net of $0 for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2012-11-05
- Siga Technologies INC increase (decrease) in accrued interest receivable, net for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- Siga Technologies INC increase (decrease) in accrued interest receivable, net for the quarter ending 2011-09-30 was $150.00.
- Siga Technologies INC increase (decrease) in accrued interest receivable, net for the quarter ending 2010-09-30 was $0.00.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 6 month | Increase (Decrease) in Accrued Interest Receivable, Net 9 month |
|---|---|---|---|
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $0.00 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-06 | ||
| 2011-09-30 | $150.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $7.72K 10-Q · filed 2012-11-05 | |
| 2011-06-30 | $7.57K 10-Q · filed 2012-08-06 | ||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $0.00 10-Q · filed 2011-11-08 | |
| 2010-06-30 | $0.00 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |